ABPI and BIVDA are holding the third biopharma-diagnostics networking event 'Generating a NICE assessment for stratified medicines'.
The event will open with scene-setting perspectives on Health Technology Assessment for personalised medicines from our confirmed speakers:
• Adrian Newland, Chair, NICE Diagnostics Advisory Committee• Greg Rossi, Vice-President, Payer & Real World Evidence, AstraZeneca • Berwyn Clarke, Chairman, NALIA Systems Ltd
These will be followed by a panel session, when the speakers will take questions from the audience. Discussion will continue over networking and drinks.
When? Monday 20 January 2014, 4.30-7.30pmWhere? Central London venue to be confirmed
To reserve your place, please email Ivan Dennie, ABPI Events Manager, email@example.com